These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8733499)

  • 21. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum.
    Sun F; Tai S; Lim T; Baumann U; King M
    Can Respir J; 2002; 9(6):401-6. PubMed ID: 12522485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro evaluation of mucolytic activities of some expectorants using porcine gastric mucin].
    Misawa M; Imamura N
    Nihon Yakurigaku Zasshi; 1988 Oct; 92(4):263-70. PubMed ID: 2468589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chest physiotherapy in cystic fibrosis: short-term effects of autogenic drainage preceded by wet inhalation of saline versus autogenic drainage preceded by intrapulmonary percussive ventilation with saline.
    Van Ginderdeuren F; Verbanck S; Van Cauwelaert K; Vanlaethem S; Schuermans D; Vincken W; Malfroot A
    Respiration; 2008; 76(2):175-80. PubMed ID: 18042976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THE VALUE OF A MUCOLYTIC AGENT IN SURGICAL CARE.
    WEBB WR; DEGERLI IU; APPLEWHITE CW
    Bull Soc Int Chir; 1965; 24():71-9. PubMed ID: 14300791
    [No Abstract]   [Full Text] [Related]  

  • 25. Mucolytic effects of domiodol in tracheostomized patients after total laryngectomy. Double-blind, placebo-controlled, randomized pilot study with four-month follow-up.
    Antonelli A; Carraro A; Donati C; Garrubba V
    Arzneimittelforschung; 1992 Feb; 42(2):126-32. PubMed ID: 1610421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of oral N-acetylcysteine on mucus clearance.
    Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
    Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study.
    Jackson IM; Barnes J; Cooksey P
    J Int Med Res; 1984; 12(3):198-206. PubMed ID: 6376210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rheology of bronchial secretions and mucociliary transport (author's transl)].
    Puchelle E; Girard F; Zahm JM
    Bull Eur Physiopathol Respir; 1976; 12(6):771-9. PubMed ID: 1016804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEW MUCOLYTIC AGENTS FOR SPUTUM LIQUEFACTION.
    WEBB WR
    Postgrad Med; 1964 Nov; 36():449-53. PubMed ID: 14212497
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
    Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
    Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of salben on the rheological properties of the bronchial secretion].
    Marinin VF; Kakhnovskiĭ IM; Sorokina LA; Smirnova ZV; Arkhipova SV
    Ter Arkh; 1998; 70(3):29-32. PubMed ID: 9575584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetylcysteine in patients with COPD exacerbations associated with increased sputum.
    Ayfer Aytemur Z; Baysak A; Ozdemir O; Köse T; Sayiner A
    Wien Klin Wochenschr; 2015 Apr; 127(7-8):256-61. PubMed ID: 25595117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M; Dasgupta B; Tomkiewicz RP; Brown NE
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial.
    van der Hoeven SM; Binnekade JM; de Borgie CA; Bosch FH; Endeman H; Horn J; Juffermans NP; van der Meer NJ; Merkus MP; Moeniralam HS; van Silfhout B; Slabbekoorn M; Stilma W; Wijnhoven JW; Schultz MJ; Paulus F
    Trials; 2015 Sep; 16():389. PubMed ID: 26329352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D; Stanford G
    Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pilot study of amiloride inhalation in children with cystic fibrosis].
    Riedler J; Huttegger I
    Klin Padiatr; 1992; 204(3):158-62. PubMed ID: 1614182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
    Dasgupta B; King M
    Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Flooding' of the lungs and severe dyspnea in a patient with bronchoalveolar carcinoma.
    Keizer RJ; Beijnen JH; Baas P
    J Oncol Pharm Pract; 2011 Sep; 17(3):270-3. PubMed ID: 20194577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the effect of nebulized N-acetylcysteine on sputum consistency.
    Hirsch SR; Kory RC
    J Allergy; 1967 May; 39(5):265-73. PubMed ID: 5337455
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.